Lycia Therapeutics Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYCA and other ETFs, options, and stocks.About LYCA
Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases.
CEOAetna Wun Trombley
CEOAetna Wun Trombley
Employees65
Employees65
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2019
Founded2019
Employees65
Employees65
LYCA Key Statistics
Market cap1.20B
Market cap1.20B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today$28.70
High today$28.70
Low today$22.19
Low today$22.19
Open price$28.55
Open price$28.55
Volume771.01K
Volume771.01K
52 Week high—
52 Week high—
52 Week low—
52 Week low—
Stock Snapshot
The current Lycia Therapeutics Inc.(LYCA) stock price is $23.00, with a market capitalization of 1.2B.
As of 2026-10-23, Lycia Therapeutics Inc.(LYCA) stock has fluctuated between $22.19 and $28.70. The current price stands at $23.00, placing the stock +3.7% above today's low and -19.9% off the high.
The Lycia Therapeutics Inc.(LYCA)'s current trading volume is 771.01K.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.